ContractStudy Grant Agreement • June 28th, 2017
MERCKNON-INTERVENTIONAL STUDY GRANT AGREEMENT MERCKSMLOUVA O (IST)–POSKYTNUTÍ GRANTU PRO NEINTERVENČNÍ STUDII EFFECTIVE DATE: DATUM PLATNOSTI: This Non-Interventional Study Grant Agreement (“Agreement”) is effective as of the date set forth above (“Effective Date”) and is between Merck spol. s r.o, Na Hřebenech II 1718/10, Prague 140 00, Czech Republic (“Merck”), and Tato Smlouva O POSKYTNUTÍ GRANTU PRO NEINTERVENČNÍ STUDII („IST“)(„Smlouva“) je platná od data stanoveného výše („Datum platnosti“) a je uzavřena mezi Merck spol. s r.o, Na Hřebenech II 1718/10, Praha 140 00, Česká republika („Merck“), a University hospital Pilsen, Department of clinical oncology (the “Institution”): Fakultní nemocnicí Plzeň, onkologická a radioterapeutická klinika („Zdravotnické zařízení“): Street Address: 80, Alej Svobody Ulice: Alej Svobody 80 City, Postal Code: Pilsen, 304 60 Město, PSČ: Plzeň, 304 60 Country: Czech Republic Země: Česká republika Telephone Number: XXX Telefonní číslo: XXX Fax Number:
PRECLINICAL LAB STUDY GRANT AGREEMENT (Institution's IND)Study Grant Agreement • July 15th, 2009
Grant Agreement, made this ____ day of _____, 1994, by and between THE UNIVERSITY OF TEXAS ______ (hereinafter referred to as "INSTITUTION"), a component institution of The University of Texas System (hereinafter referred to as "System"), located at _______ and Hoffmann-La Roche Inc., a subsidiary of [Hoffmann-La Roche Inc./Roche Laboratories], a New Jersey Corporation (hereinafter referred to as "ROCHE") located at 340 Kingsland Street, Nutley, New Jersey 07110-1199.
